Combination of Hedgehog inhibitors and standard anticancer agents synergistically prevent osteosarcoma growth

Author：

E-ISSN： 1791-2423|48|1|235-242

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.48, Iss.1, 2016-01, pp. : 235-242

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mutant B-Raf Kinase Inhibitors as Anticancer Agents

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 12, 2016-12 ,pp. : 1558-1575

Bentham Science Publishers

Access to resources Recommend Favorite

CDC25 Inhibitors as Anticancer Agents Are Moving Forward

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 8, 2008-12 ,pp. : 857-862

Bentham Science Publishers

Access to resources Recommend Favorite

Combination treatment with doxorubicin and microRNA-21 inhibitor synergistically augments anticancer activity through upregulation of tumor suppressing genes

International Journal of Oncology, Vol. 46, Iss. 4, 2015-01 ,pp. : 1589-1600

Spandidos Publications

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor Antagonists as Anticancer Agents

By Jurjees Hasan Gordon C. Jayson

American Journal of Cancer, Vol. 3, Iss. 4, 2004-01 ,pp. : 229-245

Adis International

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors: A New Wave of Molecular Targeted Anticancer Agents

Recent Patents on Anti-Cancer Drug Discovery, Vol. 2, Iss. 2, 2007-06 ,pp. : 119-134

Bentham Science Publishers

Access to resources Recommend Favorite